Iron as a trigger of neurodegeneration in Parkinson's disease
Authors:
- Jolanta Galazka‐FriedmanJGJolanta Galazka‐Friedman
- Erika R. BaumingerEBErika R. Bauminger
- 1 January 2007
- book chapter
- Published by Elsevier
- Vol. 83, 493-505
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Inflammation and the Degenerative Diseases of AgingAnnals of the New York Academy of Sciences, 2004
- Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigraBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2003
- Magnetic resonance relaxometry in Parkinson's diseaseNeurological Sciences, 2002
- The ferritins: molecular properties, iron storage function and cellular regulationBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1996
- Does iron play a role in Parkinson's disease?Hyperfine Interactions, 1994
- The Role of the L-Chain in Ferritin Iron IncorporationJournal of Molecular Biology, 1994
- Transcranial color-coded real-time sonography in adults.Stroke, 1990
- Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal of Neural Transmission, 1988
- Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.Journal of Neurology, Neurosurgery & Psychiatry, 1924